Artem Harutyunyan, the co-founder and CTO of Bardeen, joins us to discuss how his company helps automate browser-based workflows. Bardeen raised a $15.3 million Series A round this year to grow their engineering and AI teams. Artem also shared with us his thoughts on the importance of students from Armenia having opportunities to study at universities abroad, emphasizing the perspective shift that comes from being exposed to new environments, and how they are able to impact Armenia positively when they return to the country.
Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry.
Arsen Stepanyan, the co-founder and CEO of Orders.co, joins us to discuss what challenges and opportunities there are in building software as a service (SaaS) solutions for the restaurant industry. Orders.co is a Los Angeles-based order and menu management system for small- and medium-sized restaurants. We also discussed Arsen’s efforts to build a team for his company in Armenia, and what lessons he’s drawn from his experience.
This week on EVN Disrupt we are continuing our series of podcasts from the Science and Technology Convergence Conference. Once again, we have two guests on this week’s podcast. Our first guest is Ashot Papoyan, a biotech executive who is the Chief Operating Officer at Biosim and CEO of Elm Tree Research. Our second guest is Haig Eskandarian, a microbiologist at the University of California, San Francisco. With our two guests we spoke about experimental biology and commercializing science findings in the biotech industry.
This week on EVN Disrupt we are continuing our series of podcasts from the Science and Technology Convergence Conference. We have two guests on this week’s podcast. Our first guest is Viken Douzdjian, the managing partner at Argonoutic Ventures. He shared with us his perspective on the Armenian venture capital ecosystem and how he sees the future of venture funding for the Armenian startup ecosystem. Our second guest is Levon Budagyan, the founder of Waveye. Levon is one of the early members of the Armenian tech scene. We discussed with him how the tech industry in Armenia has evolved over the last decade, and the problems they’re working to solve with WaveEye.
This week on EVN Disrupt we are launching a new series of podcasts that were recorded with guests and participants of the Science and Technology Convergence Conference that took place on September 28-29, 2022. Our first guest of the series is Dr. Mary Papazian, the former president of San Jose State University. We discussed the evolving role of the university today, and her thoughts on Armenia’s higher education ecosystem.
This week on EVN Disrupt, Marina Aghayan, the co-founder of AIP Tech and Fact Industries, joins us to discuss the potential that 3D printing has for solving real-world problems. AIP Tech is an Armenian company that 3D prints devices for the medical and aerospace industries. AIP Tech volunteered to help veterans of the 2020 Artsakh War with varying bone injuries with customized 3D implants to help them return to normal life.
This week on EVN Disrupt, Stepan Aslanyan, the co-founder and CEO of Hexact, joins us to discuss the problems they are working on solving by building no-code business intelligence tools. We also discussed Stepan’s long business career in Armenia and his thoughts on the country’s business culture.
Zareh Zurabyan, the head of the Americas division at eLabNext, a European biotech company, joins us to discuss problems the biotech industry is currently working to solve. Zareh describes who the different players in biotech ecosystems are and what trends he is seeing in the industry in 2022. We also discussed his efforts to mentor Armenian start-ups and his thoughts on Armenia’s biotech scene.
This week on EVN Disrupt, Karen Vardanyan, a founding partner at FormulaVC, joins us to discuss their firm’s investment strategy and what early stage start-ups they’re seeing in the Armenian ecosystem. We also discussed what the current global economic situation means for Armenian start-ups, and what the future of the venture capital space in Armenia may look like.